Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Glycopeptide Antibiotics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The global glycopeptide antibiotics market is anticipated to experience significant growth, expanding from a valuation of $3.31 billion in 2023 to an estimated $5.02 billion by 2028, as reported in a thorough market research publication recently added to our extensive database. The forecast period is set to see a robust compound annual growth rate (CAGR) of 8.8%, marking a notable increase in market size and impact.
The market's vigorous expansion can be attributed to several key factors, including the escalating problem of antibiotic resistance, a surge in the incidence of infectious diseases, and heightened investments in health infrastructure across various regions. An increase in governmental initiatives, fostering a collaborative approach towards addressing health emergencies and promoting antibiotic stewardship, is further fueling this growth.
Rising Cancer and Infectious Disease Cases Propel Market Demand
The study highlights the critical role of glycopeptide antibiotics in managing infections, particularly those resistant to other antibiotic classes. With the prevalence of cancer and infectious diseases on the rise, the demand for these antibiotics is intensifying. The market's forward momentum is also reinforced by the growing challenge of gram-positive infections, with effective treatments being pivotal in combating species like Staphylococcus aureus and Streptococcus pneumoniae.
- Product innovation is spotlighted as a key trend within the market, showcasing the continuous efforts by research institutions and pharmaceutical companies to improve the efficacy and safety of glycopeptide antibiotics.
- Strategic partnerships and acquisitions such as Cumberland Pharmaceuticals Inc.'s new alliances in the Middle East and ANI Pharmaceuticals Inc.'s expansion through the acquisition of Novitium Pharma are shaping the competitive landscape and driving growth.
North America Dominates the Market; Asia-Pacific Set to Exhibit Significant Growth
Geographical analysis reveals that North America holds the largest market share, a testament to its advanced healthcare sector and substantial healthcare spending. However, rapid market expansion is also anticipated in the Asia-Pacific region, driven by evolving healthcare infrastructure and heightened awareness about health and hygiene.
The research details a comprehensive set of data, including market dynamics, segmentation, and future trends. It categorizes the market based on the type of drugs - including vancomycin, dalbavancin, and oritavancin, among others - and end-users such as hospitals, specialty clinics, and home care. Serving as a quintessential resource for stakeholders, this report provides a panoramic view of the current market scenario and future prospects.
The global glycopeptide antibiotics market research report serves as an essential tool for anyone looking to understand the market's trajectory, with in-depth analysis shaping the industry's future landscape. The detailed insights offered in this comprehensive publication are poised to assist industry professionals, investors, researchers, and others interested in gauging the pulse of the glycopeptide antibiotics market.
A selection of companies mentioned in this report includes
- ANI Pharmaceuticals Inc.
- Fresenius SE & Co. KGaA
- Pfizer Inc.
- Mylan N.V.
- Novartis AG
- Hikma Pharmaceuticals Plc.
- Aurobindo Pharma Limited
- Abbvie Inc.
- Melinta Therapeutics Inc.
- Cumberland Pharmaceuticals Inc.
- Theravance Biopharma Inc.
- Janssen Global
- Bristol-Myers Squibb Company
- GSK Plc.
- Allergan Plc.
- Shenwei Pharmaceutical Hainan Co. Ltd.
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Lytix Biopharma
- Alvogen
- Eli Lilly and Company
- Bayer AG
- Merck & Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi SA
- Targanta Therapeutics
- GlaxoSmithKline plc
- Johnson & Johnson
- AstraZeneca
- Boehringer Ingelheim GmbH
- Cipla Inc.
For more information about this report visit https://www.researchandmarkets.com/r/syzjcv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
